Due to significant changes to the intellectual property (IP) landscape, the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) indeed poses major challenges to Vietnam in implementing its obligations. Most of the obligations aim to enhance protection for IP proprietors. This will have a particular impact on the life science sectors, benefitting foreign pharmaceutical...

The possibility of invalidating a patent is clearly set out in Vietnam’s intellectual property laws. Historically, however, although thousands of patents are granted each year in Vietnam, the number of requests for invalidation has been extremely small. Nearly all of these cases have occurred in the context of patent disputes where the sanctioned party (in administrative measures) or defendant...

  JOIN US INTA 2019 Dear Colleagues We will be attending the 141st INTA Annual Meeting in Boston (Massachusetts) from May 18th to May 22nd, 2019 If you have any queries on IP matters in Vietnam, please feel free to contact us at This email address is being protected from spambots. You need JavaScript enabled to view...

Since the entry into effect of the 2016 Law on Pharmacy and the subsequent Decree 54/2017/ND-CP (Decree 54), pharmaceutical companies in Vietnam were eagerly awaiting a replacement for Circular No. 44/2014/TT-BYT on drug registration (Circular 44), which was based on the now-defunct Law on Pharmacy of 2005. Finally, on November 12, 2018, Circular No. 32/2018/TT-BYT (Circular 32) was issued. This...

The Government of the United Kingdom (UK) has published a draft statutory instrument that, if approved by the UK Parliament, would provide for continued protection in the UK for marks in international applications and registrations under the Madrid System in which the European Union (EU) has been designated. Such provisions would only apply in the event of a ‘no‑deal’ Brexit. WIPO is releasing...